Bao-Rong Zhang
Overview
Explore the profile of Bao-Rong Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu Q, Wang Y, Wang C, Jiang S, Zhang B, Tian J
Sci Rep
. 2025 Mar;
15(1):7847.
PMID: 40050654
Parkinson's disease (PD), the second most prevalent neurodegenerative disorder, poses significant challenges to single-target therapeutic strategies due to its complex etiology. This has driven interest in multi-target approaches, particularly those...
2.
Xu Q, Wang J, Wang Y, Zhang B, Tian J
Parkinsonism Relat Disord
. 2025 Jan;
132:107268.
PMID: 39837722
No abstract available.
3.
Jiang S, Wang Y, Xu Q, Gu L, Kang R, Yang W, et al.
NPJ Parkinsons Dis
. 2023 Jul;
9(1):117.
PMID: 37491350
Peripheral immune cells play a vital role in the development of Parkinson's disease (PD). However, their cytokine and chemokine secretion functions remain unclear. Therefore, we aimed to explore the cytokine...
4.
Wang Z, Liu Y, Li Y, Wei Q, Lin R, Kang R, et al.
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37239999
DNA damage and defective DNA repair are extensively linked to neurodegeneration in Parkinson's disease (PD), but the underlying molecular mechanisms remain poorly understood. Here, we determined that the PD-associated protein...
5.
Wang Z, Li Y, Pu J, Zhang B
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047285
Parkinson's disease (PD) is the second most common neurodegenerative disease around the world; however, its pathogenesis remains unclear so far. Recent advances have shown that DNA damage and repair deficiency...
6.
Yan Y, Zheng R, Liu Y, Ruan Y, Lin Z, Xue N, et al.
Aging Cell
. 2023 Apr;
22(6):e13834.
PMID: 37029500
Microglial hyperactivation of the NOD-, LRR-, and pyrin domain-containing 3 (NLRP3) inflammasome contributes to the pathogenesis of Parkinson's disease (PD). Recently, neuronally expressed NLRP3 was demonstrated to be a Parkin...
7.
Chen Y, Zhang L, Fang Y, Li C, Xia D, Zhang G, et al.
Eur J Neurol
. 2023 Jan;
30(11):3462-3470.
PMID: 36694359
Background And Purpose: Intestinal inflammation and gut microbiota dysbiosis contribute to Parkinson disease (PD) pathogenesis, and growing evidence suggests associations between inflammatory bowel diseases (IBD) and PD. Considered as markers...
8.
Vollstedt E, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, et al.
Mov Disord
. 2023 Jan;
38(2):286-303.
PMID: 36692014
Background: As gene-targeted therapies are increasingly being developed for Parkinson's disease (PD), identifying and characterizing carriers of specific genetic pathogenic variants is imperative. Only a small fraction of the estimated...
9.
Liu J, Chen Y, Shi D, Zhang B, Pu J
Curr Neuropharmacol
. 2022 Dec;
21(3):536-546.
PMID: 36582064
Background: Parkinson's disease (PD) is the second most common neurodegenerative disease with a significant public health burden. It is characterized by the gradual degeneration of dopamine neurons in the central...
10.
Shen T, Pu J, Jiang Y, Yue Y, He T, Qu B, et al.
Neural Regen Res
. 2022 Oct;
18(5):1154-1160.
PMID: 36255006
Multiple single nucleotide polymorphisms may contribute to cognitive decline in Parkinson's disease. However, the mechanism by which these single nucleotide polymorphisms modify brain imaging phenotype remains unclear. The aim of...